Oxoid cfVPB Available In Low-Density Containers
The Oxoid Cold Filterable Vegetable Peptone Broth (cfVPB), designed specifically for pharmaceutical media fill trials, is now available ready prepared in low-density bioprocess containers (BPCs). These ready-to-use bags can be connected to the user's process simulation, eliminating the need for bulk-media preparation. The BPCs are manufactured from a medical-grade plastic film that meets USP Class VI requirements and are certified free from animal-derived components.
Connection is made through a male or female connector, which is attached to the BPC with C-Flex tubing. Oxoid cfVPB is said to be ideal for production environments in the pharmaceutical industry, where there is a need to control the risk of contamination from animal-derived materials - particularly with the emergence of diseases such as transmissible spongiform encephalopathies (TSE). Maria Higgins, pharmaceutical applications manager for Oxoid products, said: 'The containers reduce waste and lower cleaning costs.
'Moreover, the BPCs minimise the risk of cross contamination, allowing companies to meet regulatory standards,' she added. Formulated using a pea peptone (digested using fungal enzymes), this is a nutritious medium that supports the growth of bacteria, yeasts and fungi when incubated under appropriate conditions. The cfVPB is gamma irradiated at a dose validated to be lethal for all yeasts, moulds and bacteria, including bacterial spores and mycoplasmas.
The BPCs are also gamma irradiated. The medium is prepared using water-for-injection-quality water. The BPCs are aseptically filled, ensuring that the prepared medium is suitable for use in pharmaceutical clean-room support areas. The product is also accompanied with quality certification providing full traceability for each batch. Oxoid cfVPB is available as standard in 10- and 20-litre-volume BPCs; other sizes can be custom made.
Connection is made through a male or female connector, which is attached to the BPC with C-Flex tubing. Oxoid cfVPB is said to be ideal for production environments in the pharmaceutical industry, where there is a need to control the risk of contamination from animal-derived materials - particularly with the emergence of diseases such as transmissible spongiform encephalopathies (TSE). Maria Higgins, pharmaceutical applications manager for Oxoid products, said: 'The containers reduce waste and lower cleaning costs.
'Moreover, the BPCs minimise the risk of cross contamination, allowing companies to meet regulatory standards,' she added. Formulated using a pea peptone (digested using fungal enzymes), this is a nutritious medium that supports the growth of bacteria, yeasts and fungi when incubated under appropriate conditions. The cfVPB is gamma irradiated at a dose validated to be lethal for all yeasts, moulds and bacteria, including bacterial spores and mycoplasmas.
The BPCs are also gamma irradiated. The medium is prepared using water-for-injection-quality water. The BPCs are aseptically filled, ensuring that the prepared medium is suitable for use in pharmaceutical clean-room support areas. The product is also accompanied with quality certification providing full traceability for each batch. Oxoid cfVPB is available as standard in 10- and 20-litre-volume BPCs; other sizes can be custom made.
Comments